Gulf Lloyds India Ltd vs Sheel Biotech Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 27, 2026

Key Highlights

The Latest Trading Price of Gulf Lloyds (India) Ltd is ₹ 29.71 as of 26 Oct 15:30 . The P/E Ratio of Gulf Lloyds (India) Ltd is 0 as of March 2026 .The P/E Ratio of Sheel Biotech Ltd is 0 as of March 2026 . The Market Cap of Gulf Lloyds (India) Ltd is ₹ 0 crore as of March 2026 .The Market Cap of Sheel Biotech Ltd is ₹ 0 crore as of March 2026 . The Dividend Payout of Gulf Lloyds (India) Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Sheel Biotech Ltd changed from 28.46 % on March 2022 to 0 % on March 2026 . This represents a CAGR of -100.00% over 5 years .

About Gulf Lloyds (India) Ltd

Gulf Lloyds (India) Limited was originally incorporated as 'Gulf Lloyads Industrial Services (India) Private Limited' dated September 26, 2014, with the Assistant Registrar of Companies, Gujarat.
Subsequently, the name of the company was changed to Gulf Lloyds Industrial Services (India) Private Limited and again was changed to Gulf Lloyds (India) Private Limited on September 10, 2024.
Thereafter, the name of the Company was changed to Gulf Lloyds (India) Limited vide fresh Certificate of Incorporation obtained from the Central Processing Centre on January 20, 2025. The Company is engaged in providing inspection, verification, auditing, training and certification for government bodies, public sector enterprises, and private organizations engaged in infrastructure, industrial, and engineering activities and the testing services to clients operating across various industries.

About Sheel Biotech Ltd

Sheel Biotech Limited was incorporated as a Private Company as 'Sheel Biotech Private Limited' dated November 26, 1991, with the Registrar of Companies, Delhi & Haryana.
Further, Company was converted into a Public Limited Company w.e.f.
April 02, 1992. The Company was founded by Dr. Satya Narayan Chandak in 1991.
Thereafter, through his vision he led the stone of Tissue Culture lab wherein for advancement of lab he deputed two of his scientists to Netherlands for training to expand the business ventured in domestic market too and then added greenhouse division to promote protected cultivation.
The Company started the Import division in 2019 and importing tulip, glad, lilium, orchids and alstromeria.

FAQs for the comparison of Gulf Lloyds (India) Ltd and Sheel Biotech Ltd

Which company has a larger market capitalization, Gulf Lloyds (India) Ltd or Sheel Biotech Ltd?

Market cap of Gulf Lloyds (India) Ltd is 19 Cr while Market cap of Sheel Biotech Ltd is 119 Cr

What are the key factors driving the stock performance of Gulf Lloyds (India) Ltd and Sheel Biotech Ltd?

The stock performance of Gulf Lloyds (India) Ltd and Sheel Biotech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Gulf Lloyds (India) Ltd and Sheel Biotech Ltd?

As of October 27, 2026, the Gulf Lloyds (India) Ltd stock price is INR ₹29.71. On the other hand, Sheel Biotech Ltd stock price is INR ₹58.95.

How do dividend payouts of Gulf Lloyds (India) Ltd and Sheel Biotech Ltd compare?

To compare the dividend payouts of Gulf Lloyds (India) Ltd and Sheel Biotech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.